Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.
Giant cell (GCA) and Takayasu's arteritis (TAK) are 2 forms of large-vessel vasculitis (LVV) that involve the aorta and its major branches. GCA has a predilection for the cranial branches, while TAK tends to affect the extracranial branches. Both disorders may also cause nonspecific constitutio...
Main Authors: | Direskeneli, H, Aydin, S, Kermani, T, Matteson, E, Boers, M, Herlyn, K, Luqmani, R, Neogi, T, Seo, P, Suppiah, R, Tomasson, G, Merkel, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
by: Merkel, P, et al.
Published: (2011) -
Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
by: Merkel, P, et al.
Published: (2009) -
Current status of outcome measure development in vasculitis.
by: Merkel, P, et al.
Published: (2014) -
DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
by: Luqmani, R
Published: (2011) -
Systemic vasculitis--is it time to reclassify?
by: Watts, R, et al.
Published: (2011)